mitomycin has been researched along with gentian violet in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Allen, JE; Cheng, H; Dicker, DT; El-Deiry, WS; Hong, B; Humphreys, R; Liu, YY; Tai, G; Zhou, L | 1 |
2 other study(ies) available for mitomycin and gentian violet
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; DNA Fragmentation; DNA Primers; Enzyme Activation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gentian Violet; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Mitomycin; Neoplasms; Propidium; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction | 2012 |